https://es.marketscreener.com/cotizacion/accion/NEUROSENSE-THERAPEUTICS-L-130483704/noticia/Neurosense-Therapeutics-Ltd-Finaliza-la-inscripci-n-en-el-ensayo-cl-nico-de-fase-2B-de-ELA-43885108/?utm_source=telegram&utm_medium=social&utm_campaign=share